Skip to main content
logo
Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
66.36
-1.17 (-1.73%)
At close: Nov 10, 2026, 4:00 PM EST
66.58
+0.22 (0.33%)
After-hours: Nov 10, 2026, 7:30 PM EST

Vaxcyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,148-766.63-463.93-402.27-223.49-100.08
Depreciation & Amortization
33.7924.8615.8510.179.453.46
Loss (Gain) From Sale of Assets
-----0.1
Loss (Gain) From Sale of Investments
-8.28-14.43-38.7-34.78-0.951.41
Stock-Based Compensation
156.3138.8584.8248.7623.6510.73
Other Operating Activities
17.3-34.774.23-8-
Change in Accounts Payable
20.119.9134.5811.232.9-12.47
Change in Other Net Operating Assets
-32.72-23.36-89.4870.19.84-24.54
Operating Cash Flow
-962.01-655.58-452.63-296.79-170.6-121.39
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-32.75-56.97-119.16-67.88-5.84-6.56
Sale of Property, Plant & Equipment
-----0.03
Investment in Securities
232.96494.33-1,887-705.4380.43-205.78
Investing Cash Flow
200.21437.35-2,006-773.3174.59-212.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
629.3713.012,463643.69862.4117.8
Repurchase of Common Stock
-25.01-10.99-14.29-3.88-0.86-
Financing Cash Flow
604.372.012,449639.81861.5517.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.612.440.43-6.690.14-0.44
Net Cash Flow
-155.83-213.77-9.36-436.97765.67-316.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-994.76-712.55-571.79-364.67-176.44-127.95
Free Cash Flow Growth
------
Free Cash Flow Per Share
-6.99-5.24-4.69-3.75-2.72-2.46
Levered Free Cash Flow
-529.82-430.85-403.44-202.41-107.53-88.16
Unlevered Free Cash Flow
-529.82-430.85-403.44-202.41-107.52-88.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.01
Change in Working Capital
-12.62-3.45-54.981.3212.74-37.01
SEC Filings: 10-K · 10-Q